PAI-1 (Plasminogen Activator Inhibitor-1)

What is PAI-1 (Plasminogen Activator Inhibitor-1)?

A protein that slows clot breakdown; studied as a marker relevant to inflammation and cardiovascular clotting balance.

Plasminogen activator inhibitor-1 (PAI-1) is a protein that inhibits the enzymes responsible for breaking down blood clots, making it a key regulator of the body's clot-dissolving (fibrinolytic) system. It relates to both the cardiovascular and immune systems, since PAI-1 is produced by fat tissue, blood vessel lining cells, and immune cells, and its levels tend to rise during inflammation. Researchers have studied PAI-1 in relation to cardiovascular risk, metabolic health, and clotting balance, as higher levels may be linked with reduced clot breakdown. Clinicians may consider PAI-1 testing in research or specialized settings when evaluating unexplained clotting tendencies or as part of broader cardiovascular risk assessment, though it is not a routine screening test for most people. Results are always interpreted alongside other clotting and cardiovascular markers rather than as a stand-alone measure.

Tests often checked alongside this

• D-dimer — reflects clot breakdown activity from the opposite side of the fibrinolytic system
• Fibrinogen — a related clotting protein often assessed together
• CRP — a general marker of inflammation that can influence PAI-1
• Lipid panel — often considered together in cardiovascular risk assessment

How this can show up in how you look and feel

• May be associated with a tendency toward reduced clot breakdown in some contexts
• May be associated with metabolic or cardiovascular risk factors when persistently elevated

What can affect this marker

• Age
• Sex
• Inflammation
• Exercise
• Lab variability between assays

What to track over time

• How levels trend alongside other cardiovascular and clotting markers
• Whether changes correlate with weight, activity level, or metabolic health over time
• Repeat testing may be considered if it is part of an ongoing cardiovascular risk evaluation

What to ask your doctor

• Why was PAI-1 included in my testing panel?
• How does this fit with my broader cardiovascular risk picture?
• Are there lifestyle changes that could help support healthy clotting balance?
• Should this be followed over time or was it a one-time check?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.